cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Meiragtx Holdings Plc
2 own
4 watching
Current Price
$5.41
$-0.06
(-1.1%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
391.44M
52-Week High
52-Week High
8.35000
52-Week Low
52-Week Low
3.49000
Average Volume
Average Volume
0.13M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization391.44M
icon52-Week High8.35000
icon52-Week Low3.49000
iconAverage Volume0.13M
iconDividend Yield--
iconP/E Ratio--
What does the Meiragtx Holdings Plc do?
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson s diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.
Read More
How much money does Meiragtx Holdings Plc make?
News & Events about Meiragtx Holdings Plc.
Globe Newswire
12 months ago
LONDONandNEW YORK, April 21, 2023 (GLOBE NEWSWIRE) -- MeiraGTx Holdingsplc(Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced two abstract presentations at the Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting. The first ...
Globe Newswire
1 year ago
- Announced positive clinical data from AQUAx AAV-hAQP1 Phase 1 trial for treatment of Grade 2/3 Radiation-Induced Xerostomia in December 2022 - Announced positive top-line data from the MGT009 Phase 1/2 clinical study demonstrating safety and improvement in multiple domains of vision in X-linked ...
Globe Newswire
1 year ago
Results from the Phase 1/2 MGT009 study presented at the American Academy of Ophthalmology (AAO) 2022 Annual Meeting set the stage for Phase 3 LUMEOS trial of botaretigene sparoparvovec in XLRP, which is actively dosing patientsLONDONandNEW YORK, Oct. 01, 2022 (GLOBE NEWSWIRE) -- MeiraGTx ...
Globe Newswire
1 year ago
--Manufacturing facilities built to accelerate development and delivery of advanced medicines to patients using state-of-the-art technology at scale, with quality appropriate for commercialization --Site reflects MeiraGTxs unique, end-to-end approach to gene therapy manufacturing to expedite ...
Globe Newswire
1 year ago
-- Recent Positive Topline Data from the Phase 1/2 Trial of Botaretigene Sparoparvovec (AAV-RPGR) for the Treatment of X-linked Retinitis Pigmentosa (XLRP) -- Financing Secured by Manufacturing Facilities Extends Cash Runway to Fourth Quarter 2024 LONDONandNEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE...
Frequently Asked Questions
Frequently Asked Questions
What is Meiragtx Holdings Plc share price today?
plus_minus_icon
Can Indians buy Meiragtx Holdings Plc shares?
plus_minus_icon
How can I buy Meiragtx Holdings Plc shares from India?
plus_minus_icon
Can Fractional shares of Meiragtx Holdings Plc be purchased?
plus_minus_icon
What are the documents required to start investing in Meiragtx Holdings Plc stocks?
plus_minus_icon
What is today’s traded volume of Meiragtx Holdings Plc?
plus_minus_icon
What is today’s market capitalisation of Meiragtx Holdings Plc?
plus_minus_icon
What is the 52-Week High and Low Range of Meiragtx Holdings Plc?
plus_minus_icon
What percentage is Meiragtx Holdings Plc down from its 52-Week High?
plus_minus_icon
What percentage is Meiragtx Holdings Plc up from its 52-Week Low?
plus_minus_icon
Current Price
$5.41
$-0.06
(-1.1%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00